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eyeblink conditioning and novel 
object recognition in the rabbit: 
Behavioral paradigms for assaying 
psychiatric diseases
Craig Weiss* and John F. Disterhoft
Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Analysis of data collected from behavioral paradigms has provided important information 
for understanding the etiology and progression of diseases that involve neural regions 
mediating abnormal behavior. The trace eyeblink conditioning (EBC) paradigm is par-
ticularly suited to examine cerebro-cerebellar interactions since the paradigm requires 
the cerebellum, forebrain, and awareness of the stimulus contingencies. Impairments in 
acquiring EBC have been noted in several neuropsychiatric conditions, including schizo-
phrenia, Alzheimer’s disease (AD), progressive supranuclear palsy, and post-traumatic 
stress disorder. Although several species have been used to examine EBC, the rabbit is 
unique in its tolerance for restraint, which facilitates imaging, its relatively large skull that 
facilitates chronic neuronal recordings, a genetic sequence for amyloid that is identical 
to humans which makes it a valuable model to study AD, and in contrast to rodents, it 
has a striatum that is differentiated into a caudate and a putamen that facilitates analysis 
of diseases involving the striatum. This review focuses on EBC during schizophrenia and 
AD since impairments in cerebro-cerebellar connections have been hypothesized to lead 
to a cognitive dysmetria. We also relate EBC to conditioned avoidance responses that 
are more often examined for effects of antipsychotic medications, and we propose that 
an analysis of novel object recognition (NOR) may add to our understanding of how the 
underlying neural circuitry has changed during disease states. We propose that the EBC 
and NOR paradigms will help to determine which therapeutics are effective for treating 
the cognitive aspects of schizophrenia and AD, and that neuroimaging may reveal bio-
markers of the diseases and help to evaluate potential therapeutics. The rabbit, thus, 
provides an important translational system for studying neural mechanisms mediating 
maladaptive behaviors that underlie some psychiatric diseases, especially cognitive 
impairments associated with schizophrenia and AD, and object recognition provides a 
simple test of memory that can corroborate the results of EBC.
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Neuropsychiatric diseases are a significant worldwide health issue. Analysis of data collected from 
behavioral paradigms has provided important information for understanding the etiology, and pro-
gression of diseases that involve neural regions mediating abnormal behavior. Behavioral paradigms 
also provide systems for testing potential treatments and therapeutics. Eyeblink conditioning (EBC) 
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is one such behavioral paradigm. This paradigm pairs a neutral 
conditioning stimulus (CS), e.g., a brief tone, flash of light, or 
vibration of whiskers with a mildly aversive stimulus to the eye or 
surrounding area in order to evoke a conditioned blink response. 
Subjects become conditioned after several pairings of the stimuli 
such that a blink is evoked in response to the CS and prior to the 
onset of the aversive unconditioned stimulus (US). Importantly, 
control experiments indicate that the learning is associative 
in nature, i.e., blinks do not tend to occur to the CS when it is 
presented in a random unpaired schedule with the US.
Learning occurs most quickly when onset of the US is delayed 
from the onset of the CS by approximately 250 ms, and when the 
CS and US overlap and coterminate in time [longer interstimulus 
intervals (ISIs) are optimal for human subjects]. The 250 ms ISI 
is the shortest interval tested in the rabbit by Schneiderman and 
Gormezano (1). Several studies have found that generation of a 
conditioned response (CR), a blink that occurs prior to the onset 
of the US and which protects the eye from the noxious stimulus, 
requires the thalamus, cerebellum, and afferent inputs from the 
brainstem to the cerebellum (2–5). However, learning the task 
is more difficult when a stimulus-free interval separates the two 
stimuli during a trial, i.e., more trials are required before CRs are 
exhibited (6). The simple addition of this stimulus-free “trace” 
interval between the two stimuli increases the memory demand 
of the task, recruits forebrain areas that would otherwise not be 
required for the task, and importantly requires awareness that the 
CS predicts the occurrence of the aversive stimulus [as reported 
by human subjects (7, 8)]. The requirement for awareness makes 
trace EBC a useful paradigm to investigate the cognitive nature 
of cerebellar function as proposed by Leiner et  al. (9, 10), and 
abnormalities in the cerebro-cerebellar circuitry that mediates 
awareness likely involves the circuitry that makes EBC sensitive 
to neuropsychiatric disease.
The distinction between the neural requirements for the delay 
and trace versions of the EBC paradigm allows behavioral testing 
to dissociate forebrain-dependent cognitive effects from a more 
basic sensorimotor integration mediated by the brainstem/cere-
bellar/thalamic systems. Although EBC has been used most often 
to study neural mechanisms mediating learning and memory in 
healthy adults, the dissociation between forebrain and cerebellar/
brainstem effects is useful in helping to characterize the effects of 
a disease state, and the effects of a potential treatment.
Several reports indicate that EBC can be used to detect impair-
ments in neuropsychiatric diseases, such as schizophrenia (11–14), 
Alzheimer’s disease [AD (15–17)], progressive supranuclear palsy 
[PSP (18)], and post-traumatic stress disorder [PTSD (19)] EBC 
is significantly impaired by AD, relative to age-matched control 
subjects (15, 17). There is the one report of EBC in patients with 
PSP, which indicates a severe impairment in acquiring EBC with 
trace intervals of 0, 300, or 600 ms (18); those authors concluded 
that the deficit was likely due to neuropathological changes in 
the cerebellar nuclei since other pathologies overlap with those 
of Parkinson’s disease (PD), which does not impair acquisition of 
EBC (20). The effects of PTSD on EBC are discussed by Schreurs 
and Burhans elsewhere in this volume (19). The EBC paradigm 
also reveals age-related learning impairments in humans (21–23), 
rabbits (24), and rats (25–28). Overall, the EBC paradigm is quite 
translational in nature. The phases of behavioral acquisition are 
similar between human and non-human subjects (although 
scaled differently) and many of the same stimuli and stimulus 
delivery systems can be used with both types of subjects (29). 
Much of our understanding of the neural networks mediating this 
conditioning comes from in vivo recordings from single neurons 
and multiunit activity in different brain regions during the task 
(30–35), and from permanent and temporary lesions of regions 
suspected to be involved in the task (3, 4, 33, 36–39).
Although this review focuses on the benefits of using the 
rabbit as the experimental subject, considerable advances have 
been made by using the mouse as a subject for EBC and deserve 
mention, especially for manipulations of the cerebellum and dif-
ferent transmitter systems. An understanding of the neurotrans-
mitters and receptors involved in conditioning and cognition 
has been facilitated by using knockout and transgenic mice, e.g., 
elimination of monoamine oxidase isoenzymes A and B increases 
levels of monoamines, including serotonin (40) and resulted in 
abnormally enhanced acquisition rates of delay EBC, elevated 
levels of hippocampal long-term potentiation, decreased ratio 
levels of NMDA receptor subunits NR2A and NR2B in prefrontal 
cortex (PFC) [increased ratio levels in hippocampus (41)] and 
the adenosine receptor has been shown to be important in both 
acquisition of EBC and the development of LTP (42). These stud-
ies are of interest given the involvement of NMDA receptors and 
serotonin in schizophrenia (43–45).
In terms of the cerebellum, elimination of cannabinoid recep-
tor 1 (CB1), which is highly expressed in cerebellum, or muta-
tions of the glutamate receptor mGluR1 (46) or subunit delta2 
which affects cerebellar cortex was found to significantly impair 
delay conditioning, but not trace conditioning [(47, 48), see Ref. 
(49) for a discussion of this result], and elimination of calcium/
calmodulin-dependent protein kinase type IV (CaMKIV), which 
is expressed in cerebellar granule and nuclear cells, impaired 
long-term retention of delay conditioned blinks (50). These stud-
ies are of interest given the role of cerebellar–cortical interactions 
with schizophrenia (51).
In terms of AD, the insertion of genes related to AD have been 
shown to accelerate impairments in mice acquiring EBC (52, 
53) and reduce the volume of their hippocampus, as measured 
with MRI (54). However, the genetic sequence for amyloid in the 
mouse is different than the sequence found in human amyloid. 
This adds the complication of foreign DNA in the host. By con-
trast, the rabbit sequence for amyloid is identical to the sequence 
in humans (55) and should minimize that complication. Lastly, 
learning specific changes in the cortical representation of the CS 
for whisker-signaled conditioning have been described (56) and 
provide a substrate for experimental manipulation.
A circuit diagram of relevant brain regions involved in trace 
and delay EBC is shown in Figure  1. Note that five modules 
have been identified: cerebellum, PFC, limbic-medial temporal, 
sensory cortex, and basal ganglia. The thalamic nuclei connecting 
the different modules are also shown (the anterior thalamus (AT) 
includes anterior dorsal, anterior ventral, and anterior medial). 
The circuit shows the flow of information representing the condi-
tioning stimuli through the cerebellum, the forebrain, and back to 
the cerebellum by way of the pontine nuclei. The disruption of any 
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of the pathways or nuclei will lead to maladaptive responses to the 
stimuli regulating learned behaviors and to disrupted executive 
functions due to changes in the PFC.
The cerebellum is a necessary component for acquisition 
and expression of conditioned blink responses (2, 57). It is one 
synapse removed from the motor neurons that control the CR 
and importantly, it provides feedback to the frontal cortex via 
the thalamus (58–60). Removal of this input may contribute 
to a cognitive dysmetria and symptoms of schizophrenia (51). 
Destruction of the cerebellar nuclei (the sole output of the cer-
ebellum) eliminates acquisition and expression of CRs, but leaves 
intact the unconditioned, reflexive eyeblink to noxious stimuli. 
The PFC is required for acquisition of EBC when the task is 
cognitively demanding as in trace conditioning or when the CS 
is relatively mild and requires attention for detection, even during 
delay conditioning (61). Acquisition of trace EBC requires the 
caudal anterior cingulate portion of the PFC [cACC (36)], and 
long-term retention involves the prelimbic (PL) portion (35). 
Lesions of the hippocampus result in non-adaptive short-latency 
CRs or with enough damage the animal is unable to acquire CRs 
(6, 62). Lesions of SI prior to whisker-signaled trace EBC prevent 
FiGURe 1 | Trace eyeblink conditioning requires forebrain input to a cerebellar circuit that mediates conditioning. Four forebrain circuits that interact via 
thalamic nuclei (shown in red text). The limbic, medial temporal circuit is outlined in dark green and is sensitive the effects of aging. The limbic forebrain circuit is 
outlined in magenta and is affected during schizophrenia. The basal ganglia circuit is outlined in tan and is affected during supranuclear palsy. The sensory circuit is 
outlined in light green (the somatosensory system is shown in this example). The cerebellar circuit is shown to the far right. The conditioning stimulus (CS) is 
conveyed to the cerebellum via mossy fibers originating in the pontine nuclei; the unconditioned stimulus (US) is conveyed via climbing fibers from the inferior olive. 
AT, anterior thalamus; cACC, caudal anterior cortex; Cd, caudate; DG, dentate gyrus; EC, entorhinal cortex; GPi, globus pallidus internal; MD, medial dorsal 
thalamus; MNs, motor neurons (facial and accessory abducens for blink conditioning); PFC, prefrontal cortex; PL, prelimbic cortex; PR, perirhinal cortex; rACC, 
rostral anterior cingulate cortex; rDAO, rostral dorsal accessory olive; RE, nucleus reuniens; RNm, magnocellular red nucleus; RS, retrosplenial cortex; SI, primary 
sensory cortex; SII, secondary sensory cortex; V, trigeminal nucleus; VA, ventral anterior thalamus; VPm, ventral posterior medial cortex; SNpc, Substantia Nigra 
pars compacta; SNpr, Substantia Nigra pars reticulata.
acquisition of CRs, but similar lesions made after consolidation 
has been allowed to occur for 30 days does not abolish CRs. We 
suggest that CS information is relayed into the hippocampal 
formation via the secondary sensory cortical system after con-
solidation has occurred. The role of the striatum was examined 
because of cognitive deficits associated with PD (63–66). Lesions 
of the caudate nucleus prevent acquisition of CRs (33) and similar 
lesions made after acquisition prevent any further improvement 
in expression of the CR (67).
Although most recording and lesion techniques are invasive 
and not appropriate to study in humans, functional magnetic 
resonance imaging can be done in both human and non-human 
animal subjects during and after learning (68–70). Blink condi-
tioning thus provides an important translational tool for studying 
the neural mechanisms mediating maladaptive behaviors that 
underlie some psychiatric diseases. Here, we review some of the 
work that has been done with schizophrenia as a prototypical 
psychiatric disease and suggest ways in which the paradigm may 
be used to test potential therapeutics.
Other neuropsychiatric diseases have also been examined 
with EBC, e.g., AD, PSP, PD, and PTSD. Briefly, AD significantly 
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impairs acquisition relative to age-matched control subjects 
(15), acquisition is normal in patients with PD but impaired in 
patients with PSP (17, 18), and PTSD has effects (especially on the 
unconditioned response) as discussed elsewhere in this issue by 
Schreurs and Burhans (19).
Schizophrenia
Schizophrenia, a neuropsychiatric syndrome that includes 
symptoms of hallucinations, delusions, and extremely disordered 
thinking affects approximately 1% of the population. Behavioral 
abnormalities related to schizophrenia usually appear in the late 
teens and causes a life-long disability. Much evidence suggests 
that schizophrenia is a neuro-developmental disorder affecting 
connections between the cerebellum and PFC, which leads 
to a cognitive dysmetria (51, 71). More recently, an analysis of 
cerebellar gray matter using a modern unbiased morphometry 
approach, rather than whole-brain voxel based morphometry, 
found that gray matter volumes in Crus I/II were significantly 
reduced among patients, and the reduction correlated with tests 
measuring thought disorders and executive functioning (72).
Schizophrenia should affect both trace and delay conditioning 
since the cerebellum is required for both the delay and trace ver-
sions of the paradigm (73), even though the PFC is not required 
for the less demanding delay paradigm when salient stimuli are 
used (36). The connections between the cerebellum and PFC 
have been studied in non-human primates by Peter Strick and his 
group (58, 60). They found that neuronal loops connect the dor-
solateral PFC and the cerebellum, and that the dentate cerebellar 
output nucleus of the loop is active during cognitive processing, 
as measured with functional magnetic resonance imaging [fMRI; 
(74)]. Cerebellar activation, as measured during fMRI based 
experiments has yielded mixed results, but a meta-analysis of 
more than 200 studies (75) found that approximately 40% of 
reports included individuals with schizophrenia and cerebellar 
hypoactivation was found in approximately two-thirds of those 
patients, mostly during tasks testing cognition and executive 
functions.
We have also used fMRI to measure the blood oxygen level-
dependent (BOLD) response from the cerebellum in rabbits con-
ditioned to evoke eyeblinks. We demonstrated learning-related 
decreases in the cerebellar cortex and learning-related increases 
in the deep cerebellar nuclei (68). We have also shown with mul-
tiple single-neuron tetrode recordings that neurons in the caudal 
anterior cingulate region (cACC) of the PFC exhibit conditioning 
specific increases in activity early in the trial sequence that appear 
to reflect a signal for attention to sensory stimuli. Conversely, neu-
rons in the prelimbic area exhibit robust neuronal activation in 
response to the CS during tests for retention of remotely acquired 
EBC, i.e., the rabbits were trained to criterion and then left in 
their home cages for 30 days (35). Although the exact homolog of 
the primate dorsolateral PFC is difficult to establish in lower spe-
cies, the activity pattern we reported for neurons in the prelimbic 
cortex appears to be a signal that reflects retrieval of the memory 
for how to respond appropriately to the conditioned stimulus, 
especially since the activity pattern was not evident during the 
relatively few trials when CRs were not expressed.
Interactions between the cerebellum and forebrain use rela-
tively long axonal tracts and information processing within the 
PFC (and elsewhere), and is dependent on the proper functioning 
of the neurons and interneurons within the region. Abnormalities 
in GABAergic neurons have been proposed to contribute to the 
symptoms of schizophrenia. Changes in the inhibitory neurons of 
the PFC, especially of the dorsolateral PFC, have been reviewed 
by Lewis et al. (76). They proposed that GABAergic neurons in 
schizophrenic patients have defects in signaling pathways such 
that expression of the messenger RNA for GAD67, an enzyme 
involved in the synthesis of GABA, is reduced and postsynaptic 
GABAA receptors are upregulated. These deficits in the PFC could 
account for the disturbances in working memory (43), possibly 
due to a hypoglutamatergic state since antagonists of NMDA 
receptors, e.g., ketamine or phencyclidine (PCP), induce halluci-
nations similar to those observed in people with schizophrenia, 
and administration of PCP prevents acquisition of trace, but not 
delay EBC in rabbits (77).
Myelination defects in the cerebellar–prefrontal tracts are 
also thought to be involved in schizophrenia and have been 
hypothesized to lead to a functional disconnection between the 
two regions and a cognitive dysmetria (71). This disconnection 
could account for the hypoactivation found in the PFC of schizo-
phrenic patients during imaging studies (78). A study of intrinsic 
connectivity between the cerebellum and the rest of the brain in 
schizophrenic patients, their siblings, and controls supports the 
hypothesis of a functional disconnection (79). This study found 
that patients had significantly impaired connectivity between the 
cerebellum and forebrain regions, including the hippocampus, 
thalamus, and middle cingulate gyrus (79). Each of these brain 
regions, and the cerebellum, are critically involved in mediating 
trace EBC (3, 4, 6, 31, 36, 38, 79–81).
Schizophrenia and Blink Conditioning 
Studies
The literature discussed so far suggest that patients with schizo-
phrenia should have impaired acquisition of both delay and 
trace EBC because of defects in the cerebellum and thalamus/
PFC, respectively. However, initial studies of EBC in patients 
with schizophrenia yielded mixed results. A review by Lubow 
(82) concluded that the inconsistencies in results were likely 
due to differences in the medication history of the patients. 
Lubow’s conclusion was that the comparison between controls 
and patients that have or have not been medicated needs to be 
done in the same study to determine if symptoms are due to the 
disease per  se, or due to interactions with medications. Those 
types of studies have been done (with delay conditioning) since 
the review by Lubow (11, 13, 82, 83); all of these more recent 
studies found that the groups with schizophrenia had impaired 
performance as compared to matched control subjects. The report 
by Coesmans et al. (83) is noteworthy in that the patients were 
recently diagnosed with schizophrenia (which limited the effects 
of medication), and no consistent effect of medication was found 
on conditioning (clozapine vs. haloperidol), i.e., all patient groups 
were impaired relative to control subjects. A report by Bolbecker 
(84) is also noteworthy in that a cerebellar dependence was 
October 2015 | Volume 6 | Article 1425
Weiss and Disterhoft Conditioning, NOR and psychiatric disease
Frontiers in Psychiatry | www.frontiersin.org
demonstrated by the subcutaneous administration of secretin (an 
agonist of group B G-protein coupled receptors), which acts as a 
retrograde messenger and neuromodulator on cerebellar basket 
and Purkinje cells. The compound significantly improved delay 
EBC in medically stable schizophrenic patients, as compared to 
patients that received a placebo control (controls showed no sig-
nificant improvement in performance across trial blocks). These 
data suggest that it is also necessary for the cerebellar cortex to 
function properly in order for conditioning to occur properly.
Although early studies examining conditioning in schizo-
phrenic patients are difficult to interpret due to differences in 
medication history, two of the studies are of particular interest in 
that they measured the level of arousal during the conditioning 
session. Mednick (85) found that the percentage of CRs corre-
lated with the subjects’ skin potentials, which indicated that the 
subjects were more aroused. Spain (86) found a similar result, 
although that experiment may have been confounded by an 
instruction to press a response key at the termination of the CS 
(1000 ms CS, 500 ms ISI, 160 ms US). These results are of interest 
due to interactions with executive functions of the PFC and the 
sensitivity of the PFC to the modality of the US used during trace 
conditioning studies. Oswald et al. (87) found that lesions of the 
PFC [anterior cingulate region (24)] impaired acquisition much 
more when the US was a puff of air to the cornea as compared to 
a shock to the periorbital region. The shock US appears to be able 
to compensate for deficits that might otherwise occur when a less 
salient stimulus is used.
The effects of arousal on responses to stimuli may be mediated 
by interactions of the PFC and hippocampal system via thalamic 
nuclei, including the anterior thalamic nuclei. This system has 
been examined with spatial memory tasks (88), but little is known 
about the system during EBC. We suggest that the greater arousal 
state of schizophrenic patients may be due to impaired circuitry 
in the prefrontal–thalamic–hippocampal system, which is then 
less able to respond properly to stimuli that are behaviorally 
important.
effects of Neurotransmitters and  
Drugs on eyeblink Conditioning
The EBC paradigm is an excellent model system to study behav-
ioral pharmacology. Several drugs and transmitter systems have 
been examined using EBC. Acetylcholine (ACh) was one of the 
first neurotransmitters examined for effects on EBC. Given the 
involvement of the hippocampus in EBC (89), and the wide-
spread role of ACh, Solomon et al. (90) examined the effects of 
scopolamine, a cholinergic, muscarinic antagonist on EBC in the 
rabbit. They found that systemically administered scopolamine 
severely impaired acquisition of delay EBC, but not when tested 
in rabbits that had their hippocampus ablated prior to the experi-
ment. This demonstrates that a malfunctioning hippocampus (due 
to low ACh) is more of a detriment to learning than having no 
hippocampus at all, and suggests that abnormal neuronal trans-
mission through the hippocampal system is likely to contribute to 
the cognitive impairments associated with schizophrenia.
Haloperidol was the next major drug examined for effects 
on EBC. This antipsychotic medication blocks dopamine (D2), 
alpha 1, and 5-HT2 (serotonin) receptors, among others, and 
has been shown to impair the acquisition rate for EBC (91). The 
impairment appeared to be due to an elevation in the threshold 
for an auditory CS to elicit CRs and suggests that the drug may 
be affecting attentional mechanisms and neuronal processing 
of the auditory cue since the effect was present when a 75 or 
85-dB tone was used, but not when a 95-dB tone was used as 
a CS (92, 93).
The effects of serotonergic receptors on cognition, psy-
choses, and EBC deserve further review. An analysis of their 
effects on EBC has been investigated by John Harvey (94). He 
and his colleagues manipulated serotonergic receptors with 
agonists and antagonists during EBC and found that lysergic 
acid diethylamide (LSD) facilitated acquisition of CRs due to 
enhanced activation of the 2A/2C receptors unless the receptors 
were blocked by an antagonist, e.g., by Ritanserin (95). Since a 
5HT1A agonist (8-OH-DPAT) had no effect, the effects of LSD 
are likely to be acting through the 2A/2C receptors rather than 
the 1A receptor. Harvey et al. (96) also increased the density of 
5HT2A receptors in the frontal cortex by injecting MDL11,939 
(a potent 5-HT2A antagonist) daily for 8 days prior to starting 
conditioning trials. The results indicated that the treated rabbits 
acquired CRs significantly faster than did rabbits given the vehi-
cle control, and rabbits given the drug and explicitly unpaired 
stimuli exhibited <5% of trials with either spontaneous blinks 
or pseudo-CRs, suggesting that the drug was not acting on non-
associative process.
Lastly, the N-methyl-d-aspartate (NMDA) receptor is the major 
excitatory receptor in the brain and is altered during learning and 
memory to facilitate ionic flow through its channel. Antagonists 
of the NMDA receptor (e.g., PCP, MK-801) are known to induce 
psychosis and have been found to impair EBC significantly in a 
dose-dependent manner in rabbits (77). Conversely, GLYX-13 (a 
novel NMDAR glycine-site functional partial agonist) facilitates 
acquisition of EBC in young and aging rats (27, 97).
Other Behavioral Paradigms for  
evaluating Schizophrenia
We have focused our discussion on EBC as a behavioral 
paradigm to evaluate the effects of the schizophrenic condition. 
This behavior could be considered as a conditioned avoidance 
response (CAR), the type of response that has classically been 
observed to evaluate the effectiveness of antipsychotic medica-
tions, i.e., suppression of the CAR (43). However, CAR paradigms 
typically evaluate responses that occur over the course of several 
seconds, as in moving away from a region to avoid a foot-shock. 
By contrast, movements related to EBC occur over the course of 
a fraction of 1 s. Regardless, both types of paradigms involve a 
CAR and should produce similar results. An examination of EBC 
under conditions that model the schizophrenic condition might 
allow a test of this hypothesis.
As alluded to earlier, EBC works so well with rabbits because 
it requires minimal behavioral output from the rabbit, and rabbits 
do not express much spontaneous behavior that might otherwise 
interfere with the behavior of interest. In terms of being able to 
use the rabbit to examine the neurobiology of schizophrenia in 
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more detail, additional behaviors would be beneficial, both to add 
support to the results from EBC and to compare the rabbit to 
other established behavioral tests that are done in rodents. The 
novel object recognition (NOR) test is a popular test for declara-
tive memory in rodents, especially for tests of schizophrenic-like 
impairments (44, 45, 98, 99). The test is done in two phases, an 
initial exploration phase where two identical objects are explored 
by the test animal, and a test phase that examines exploratory 
behavior after one of the objects has been replaced with a novel 
object after some period of time, e.g., 5–30 min. Rodents tend 
to favor the exploration of a novel object over the exploration of 
a familiar object, and the ratio of the time spent exploring one 
object relative to the other provides a cognitive index that can 
be evaluated.
The NOR paradigm has been used in rabbits by Hoffmann 
(100, 101) and was found to share similar properties with the 
rodent paradigm, i.e., the rabbits exhibited a preference for a 
novel object after a five minute delay (but not after a 20-min 
delay). Hoffman and colleagues also showed that acute 
administration of NMDA antagonists (ketamine and MK-801) 
significantly impaired NOR in the rabbits when the drug was 
administered 20  min before the sample phase of the test. The 
NOR paradigm in rabbits provides the opportunity to test the 
effects of the Meltzer paradigm for inducing schizophrenia by 
the chronic administration and subsequent washout of sub-
anesthetic doses of NMDA receptor antagonists. Those results 
can then be compared directly with results from EBC studies 
to determine if the effects are generalized to multiple tests of 
memory and cognition, and if repeated doses of NMDA antago-
nists have prolonged effects. As noted above, the relative ease 
with which BOLD imaging studies can be done in rabbits offers 
the parallel opportunity to visualize the brain regions mediating 
the potential schizophrenia-like effect.
Conclusion
Trace EBC is uniquely suited to examine cerebro-cerebellar 
interactions since the paradigm has been shown to require both 
the cerebellum and the forebrain. The additional requirement for 
awareness of the stimulus contingencies when a stimulus-free 
trace interval separates the two stimuli during a trial gives the 
paradigm good face validity. Although the paradigm has been 
used most often to study neural mechanisms mediating learning 
and memory in healthy adults, the paradigm can be used to detect 
impairments in neuropsychiatric diseases, especially schizophre-
nia. The paradigm is also quite translational in nature and animal 
models of schizophrenia can be examined with EBC in several 
species to allow an analysis from genes to molecules to behav-
ior. The paradigm is frequently used in rabbits, rats, mice, and 
humans, but the rabbit model is particularly appealing given its 
tolerance for restraint and the ease of using it without the need for 
anesthetics or sedatives during functional imaging experiments. 
An animal model of schizophrenia is particularly suited to answer 
two important questions: (1) what therapeutics are best for treat-
ing both the cognitive and psychotic aspects of schizophrenia 
and (2) can neuroimaging reveal biomarkers of the disease and a 
determination of appropriate therapeutics? Forebrain-dependent 
trace EBC in the rabbit is positioned to answer these questions, 
and the relatively new demonstration of NOR in the rabbit (100) 
provides an additional test for cognitive impairments and amelio-
ration of psychotic symptoms by antipsychotic drugs.
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